In equine ophthalmology, ulcerative keratitis is among the most common conditions and, in general, arises as a consequence of some trauma suffered. Secondarily, subsequent contamination by pathogenic or resident bacteria of the horse’s ocular microbiota may have undesirable consequences. Under physiological conditions, the normal microbiota coexists with the immune status of the host, serving as a barrier, ensuring the health of the ocular surface, and inhibiting the proliferation of pathogens. However, in the imbalance of immune barriers, the normal microbiota can become pathogenic and lead to infection, acting as an opportunistic agent. The present study aims to demonstrate the antimicrobial effect of platelet‐rich plasma (PRP), its time of action, and its correlation with the concentration of its same components in vitro on Staphylococcus sciuri, a bacterium with high prevalence in the normal ocular microbiota of horses in the municipality of Minas Gerais. For the preparation of the PRP, eight adult Quarter Horse (QH) horses were used. The individual PRP was prepared by the double centrifugation protocol, and then, the PRPs were added to a pool, followed by testing their interaction in culture with Brain Heart Infusion (BHI) broth at different dilutions against five strains collected from different animals. After 3, 6, 12, and 18 hours, the colony formation units (CFU) count on a 5% horse blood agar plate was evaluated for each time point. Our study showed that Staphylococcus sciuri, the resident microorganism of the ocular conjunctival microbiota of horses, is more susceptible when compared to the standard strain “American Type Culture Collection” (ATCC‐29213) Staphylococcus aureus, a pathogenic microorganism, which was used for the validation of our study. The antibacterial effect shown in this study was bacteriostatic for up to 6 hours. The most concentrated PRP dilutions, 1 : 1 and 1 : 2, were also most effective, suggesting that the antibacterial effect is volume dependent.

This is a case of medulloepithelioma in a 14-year-old mixed breed gelding horse, presenting a large abnormal mass of tissue involving the entire extension of the right eye. Ophthalmic examination showed deformation and swelling of the eye. The animal showed signs of pain on palpation of the organ, but the specific examination of the systems did not reveal any other changes. Due to the extension of the apparently neoplastic mass and the discomfort experienced by the animal, transpalpebral enucleation procedure was decided. The excised tissue was sent for histopathological analysis, wherein a neoplastic proliferation of neuroectodermal cells was noted. The neoplasm was poorly delimited, unencapsulated, infiltrative, sustained by moderate fibrovascular stroma, and formed cords and rosettes with cells arranged in palisades around the luminal structures (Flexner-Wintersteiner rosettes), suggestive of medulloepithelioma. The immunohistochemical profile was also performed, confirming the diagnosis. The neoplastic cells were immunolabeled to vimentin, S100 protein (S100), and specific neuro enolase (NSE), but not for pan cytokeratin (AE1AE3), glial fibrillary acidic protein (GFAP), and cytokeratin 8/18 (CK8/18). Five months postoperatively, the animal was healthy, without any relapse or evidence of metastasis.

Morphine has significant clinical and analgesic effects in horses, but its impact on the gastrointestinal tract requires further understanding. This study assessed the analgesic and gastrointestinal effects of morphine in horses undergoing elective orchiectomy in the quadrupedal position. Thirty uncastrated male horses were randomly assigned to three groups: orchiectomy without morphine and sedation protocol (OSM), orchiectomy with morphine and sedation protocol (OM), and administration of morphine alone in the absence of orchiectomy (M). The anesthetic protocol involved acepromazine (0.05 mg/kg IV) and detomidine (10 mcg/kg IV) sedation in groups OSM and OM, with morphine sulfate (0.05 mg/kg IV) given to OM and M, and NaCl to OSM. The team measured clinical parameters, pain, and sedation using the EQUUS-FAP scale, while they monitored bowel motility and gastric dilation through abdominal ultrasound. These assessments were performed on the previous day (m1), 20 min before surgery (m2), and at various time points following the administration of morphine or saline solution: one hour (m3), two hours (m4), four hours (m5), six hours (m6), and eight hours (m7) post-procedure for all three groups. There was no significant difference in pain score between OSM and OM, though OM had better sedation. Ultrasound revealed decreased colon contractions and minor gastric dilation in OSM and OM, normalizing within 6 h. Group M showed reduced motility and significant gastric dilation lasting 8 h. In conclusion, while morphine enhanced sedation without causing greater gastrointestinal dysfunction than OSM, its administration alone resulted in a more pronounced reduction in gastrointestinal motility and an increased risk of gastric dilation.

Platelet-rich plasma (PRP) has been proposed as an agent to accelerate the healing process and stimulate the regenerative capacity of tissues due to its abundance of growth factors. A large variety of kits and protocols are available to obtain PRP by different cell-separation systems. However, the lack of standardization may lead to inconsistent results. The aim of this study was to characterize cellular composition, platelet parameters using the ADVIA 120 flow cytometer, and TGF-β1 concentration from the PRP product obtained through a closed system, using simple centrifugation. Six clinically healthy horses were used in this study. The protocol in the closed system resulted in approximately 1.6-fold higher platelet and approximately 2.0-fold lower white blood cell concentrations in comparison with whole blood values. The evaluated system was efficient in concentrating platelets and in retrieving a small number of leukocytes, using a protocol of single centrifugation at low speed.

Varicellovirus equidalpha 1, formerly Equid alphaherpesvirus 1 (EqAHV-1), is prevalent globally, causing persistent infections via latency in horse populations. Viral reactivation under stress leads to new excretion and transmission, resulting in respiratory illness, abortion, neonatal foal death, and myeloencephalopathy. The neuropathogenic variant, associated with a specific neuropathogenic marker (G2254/N752), poses a higher replication rate and longer viremia duration. In Brazil, EqAHV-1's neuropathogenic strain has been identified, causing Equid Herpesvirus Myeloencephalopathy (EHM) in the states of São Paulo and Minas Gerais. The present study aimed to detect and genotype EqAHV-1 strains in abortion cases, exploring other potential etiologic agents. DNA samples from 118 samples were analyzed using PCR assays and sequencing. Results revealed EqAHV-1 DNA in 23.3% of abortion cases, with the neuropathogenic marker in 85.7% of positive samples. Leptospira spp., Brucella abortus, tick-borne pathogens and Trypanosoma evansi were considered in the differential diagnoses. EqAHV-1-positive mares had a vaccination history, but commercial vaccines didn't prevent neurological signs. The present study suggests the neuropathogenic EqAHV-1 as a significant cause of reproductive losses in Brazilian horses. Further research is needed to assess the infection's epidemiological profile and the efficacy of biosafety measures to prevent outbreaks.

Summary: The occurrence of Aural Plaques (AP) in horses, attributed to infection with Equus caballus Papillomavirus (EcPV), has become increasingly prevalent in equine breeding populations. Major challenges in managing this condition include genetic susceptibility to the virus, significant variability in individual immune responses among horses and the limited efficacy of currently available treatments. Although some treatments have shown partial success, a definitive and universally effective resolution for this condition in horses remains elusive. This case report aims to discuss the challenges encountered and findings related to the use of autohaemotherapy as a treatment for AP in four Mangalarga Marchador crossbred horses.